The Leukemia & Lymphoma Society Blog

The Leukemia & Lymphoma Society Blog

2 Posts tagged with the insurance_premiums tag

We've talked about our financial aid programs here before, but it’s good to get a reminder every now and then – especially now that we’re all feeling the crunch a little more with the slowing economy.

 

First, a few items to keep in mind:

  • Not all patients will qualify for financial assistance, but the surest way to find out is to contact us for eligibility information.

  • We receive quite a few applications on a regular basis and process them in the order that they are received, so be assured that we are working very hard to process your application if you have already submitted one.

  • If you are confused about something on the application, contact us and we’ll  explain.

 

Here is our list of financial aid programs for patients that you may be able to use:

 

  • Co-Pay Assistance Program – This program offers financial support for eligible patients towards the cost of insurance co-payments and/or insurance premium costs for prescription drugs. If you have questions about this program call the Co-Pay Assistance Program at (877) 557-2672 or email copay@lls.org and a specialist will assist you.

  • Patient Financial Aid Program – This program offers financial reimbursement for some medications, transportation and procedures. You can also contact your local chapter, and they will be able to assist you.

 

Here are a few other educational resources which you may find helpful as you try to figure out how best to manage your finances in relation to health care costs:

 

 

As always, if you have any questions please feel free to contact our Information Resource Center by sending a message via our Contact Us form or call us at (800) 955-4572. Our specialists will be happy to assist you.

0 Comments 0 References Permalink

Recently I’ve been reading some articles online about the costs of cancer medications like Avastin* and Gleevec. When insurance companies up the cost of co-pays for these medications (our very own Hildy Dillon, Senior Vice President, Patient Services responded to this NYTimes article in a letter to the editor), it can cost the patient many thousands of dollars, and even doctors and medical practices can be hard hit by the rising cost of drugs. For the patients interviewed in these articles, the benefits outweigh the costs because the drugs mean living longer, but many patients do not have the adequate monetary resources to cover the costs of their medications. It’s not even fully clear to the medical industry if the extended length of life for some patients is because of drugs like Avastin.

 

Our Public Policy team here at The Leukemia & Lymphoma Society (LLS) has also been learning about these issues of higher co-pays vs. the benefits of the cancer drugs, and they are interested in hearing if you are experiencing some of this from your insurance companies.

 

Please consider sharing your answers to the following questions.

 

Do you have to pay more for blood cancer medications than you used to?

 

Do you rely on Gleevec or any other high priced medicine? Do the benefits outweigh the cost?

 

Would you be interested in LLS fighting for lower drug co-pays?

 

Leave your answers and comments here or you can contact the Office of Public Policy by filling out our online contact form.

 

Learn more about how you can get involved with the Office of Public Policy as an advocacy volunteer.

 

*We understand that blood cancer patients do not use Avastin, but we believe that issues like this that may affect other cancer patients may ultimately affect the blood cancer patients we seek to serve.

5 Comments 0 References Permalink